Xi ‘an, Shaanxi, China-September 17, 2026

Pyrroloquinoline Quinone Disodium Salt (CAS 122628-50-6) has established itself as an essential active pharmaceutical ingredient in cellular longevity and mitochondrial optimization. However, while consumer demand for PQQ and CoQ10 co-formulations continues to climb, contract manufacturing organizations (CMOs) and R&D formulation teams face severe factory-floor bottlenecks.

At a typical clinical dose of just 10 mg to 20 mg per serving, running pure PQQ through high-speed automated encapsulation machinery introduces acute challenges: content uniformity failures, static aggregation, and moisture-induced capsule staining.

1. Solving the Blend Uniformity Bottleneck (USP )

The primary failure point in commercial PQQ manufacturing is passing dosage uniformity testing. In a standard Size 0 or 00 capsule (holding 400 mg to 500 mg of total fill weight), a 10 mg active dose accounts for merely 2% to 2.5% of the overall blend.

• The Segregation Problem: Pure crystalline PQQ disodium salt features an electrostatic surface charge and low bulk density. When blended with common excipients (microcrystalline cellulose, dicalcium phosphate) or dense actives like CoQ10, particle segregation occurs inside the hopper. High-speed vibration causes the denser particles to settle while PQQ drifts, leading to high Relative Standard Deviation (RSD > 5%) in finished dosage assays.

• The Engineering Solution:

  1. Particle Size Alignment: Ensure the particle size distribution of all excipients closely matches the PQQ active (standardized to 80–100 mesh).

  2. Geometric Dilution via PQQ Trituration: For facilities without high-shear fluid-bed granulators, formulating with a 1% or 10% PQQ Trituration (pre-dispersed on an MCC or maltodextrin carrier) eliminates micro-dispersion failure and guarantees uniform potency from the first capsule to the last.

2. Moisture Control and Hygroscopicity in Processing

PQQ disodium salt is inherently hygroscopic. When exposed to ambient relative humidity above 40% in blending suites, the raw powder rapidly absorbs atmospheric moisture.

• Consequences of Poor Moisture Control: Absorbed water causes powder agglomeration in the feed auger, resulting in uneven fill weights. Worse, within finished capsules, moisture migration causes dark orange/reddish speckling and softening of the shell.

• Formulation Safeguards:

  • Capsule Shell Selection: Formulate exclusively with low-moisture HPMC (hydroxypropyl methylcellulose) capsules. Avoid standard bovine gelatin shells, which have an equilibrium moisture content of 13%–16% that can cross-migrate into the hygroscopic PQQ core.

  • Raw Material Spec: Enforce a strict Loss on Drying (LOD) threshold of ≤ 10.0% on raw procurement, coupled with double-barrier vacuum aluminum foil packaging.

3. Engineering the PQQ + CoQ10 Dual Formulation

Pairing PQQ with Coenzyme Q10 is the clinical gold standard for mitochondrial health—CoQ10 fuels the electron transport chain, while PQQ triggers de novo mitochondrial biogenesis via PGC-1α activation.

From a manufacturing standpoint, CoQ10 is a lipophilic, low-melting-point compound (around 48°C–52°C) prone to melting under mechanical shear, while PQQ is a crystalline salt.

• Order of Addition: Blend PQQ with neutral excipients (MCC/silica) first to coat the particles and dissipate static charges before adding CoQ10.

• Thermal Management: Maintain blending suite temperatures below 22°C (72°F) to prevent localized frictional heating in tumble blenders from plasticizing the CoQ10 and encapsulating the PQQ particles in an insoluble lipid film.

4. Raw Material Sourcing: Fermented vs. Synthetic Benchmarks

Quality assurance departments must scrutinize the synthesis pathway. Chemical synthesis of PQQ frequently utilizes hazardous raw precursors and harsh catalysts, creating potential residues of pyridine, toluene, or heavy metal catalysts that fail California Proposition 65 testing.

Shaanxi Runke Plant Science & Technology Co., Ltd. supplies Microbial Fermented PQQ Disodium Salt, produced via clean non-GMO bacterial fermentation. This yields a naturally pure crystalline powder with zero harmful solvent residues.

Analytical Parameter	Shaanxi Runke Commercial Standard	Test Methodology
Chemical Name	Pyrroloquinoline Quinone Disodium Salt	Identification
CAS Number	122628-50-6	Chemical standard
Assay (Purity)	≥ 98.0% (typically ≥ 99.0%)	Agilent HPLC
Appearance	Reddish-Orange to Brownish-Red Fine Powder	Organoleptic
Granulometry	100% through 80 Mesh	Sieve test
Bulk Density	0.40 – 0.60 g/mL (Optimized for flowability)	Tapped/Loose Density Tester
Loss on Drying (Moisture)	≤ 10.0%	Halogen moisture / Vacuum oven
Lead (Pb) & Arsenic (As)	≤ 1.0 ppm each	ICP-MS (Prop 65 Compliant)
Residual Solvents	Undetected (Solvent-Free Fermentation)	GC-MS Headspace

Scale Your Mitochondrial Formulations with Confidence

Whether you require high-purity ≥98% Fermented PQQ Disodium Salt for direct encapsulation, or standardized 1% and 10% PQQ Trituration powders to solve blend uniformity on high-speed lines, Shaanxi Runke is your qualified manufacturing partner.

All our export batches are accompanied by comprehensive HPLC chromatograms, full heavy metal panels via ICP-MS, and complete technical data packages to streamline your regulatory clearance and production schedules.

About us

In the booming global Botanical Extract industry, Shaanxi Runke Plant Science & Technology Co., Ltd., strategically established as the core engine for the future by Shaanxi HUIKE Botanical Development Co., Ltd., has carried HUIKE’s more than 20 years of profound accumulation, outstanding achievements and forward-looking vision since its established in 1998.

Media Contact
Company Name: Shaanxi Runke Plant Science & Technology Co., Ltd.
Contact Person: Media Relations
Email: Send Email
Country: China
Website: https://www.runkenatural.com/